Myeloid Cells is committed to advancing knowledge of the biology, diversity, and medical relevance of myeloid cells. By publishing rigorous basic, translational, and clinical studies, the journal fosters cross-disciplinary dialogue and innovation. The journal aims to bridge mechanistic insights with therapeutic applications, supporting the development of strategies that harness myeloid cells for health and disease intervention.

We welcome manuscripts covering theoretical, experimental, preclinical, translational, and clinical aspects of myeloid cell research. Key research areas include, but are not limited to:

• Ontogeny, differentiation, and lineage plasticity of myeloid cells
• Myeloid cell heterogeneity and transcriptional regulation
• Roles in immunity, inflammation, tissue repair, and homeostasis
• Myeloid-driven pathologies in infection, autoimmunity, cancer, and metabolic disease
• Systems biology, single-cell, and multi-omics approaches to myeloid biology
• Myeloid cell interactions with tissue and stromal environments
• Biomarker discovery and diagnostic applications
• Myeloid-targeted therapeutics, including immunotherapies and regenerative medicine
• Preclinical and clinical trial studies involving myeloid-directed interventions
• Ethical, societal, and regulatory considerations in translational myeloid research

Myeloid Cells publishes original research articles, reviews, short communications, perspectives, editorials, and commentaries to serve a diverse scientific and clinical community.